BioSpace News Archive

Rhythm Pharmaceuticals, Inc. today announced four oral presentations at the 61st Annual European Society for Paediatric Endocrinology (ESPE) Meeting being held September 21-23, 2023 in The Hague, Netherlands.

Since late August the Indian state of Kerala is experiencing its fourth outbreak of the Nipah virus in five years. Nipah virus is a bat-borne virus discovered in 1999 that causes fever, vomiting, respiratory distress and encephalitis.

IceCure Medical Ltd. today announced that Lucía Graña-López, MD, PhD, a Spain-based radiologist and user of ProSense, will be presenting data using the Company’s ProSense, which is approved throughout the European Union for the treatment of malignant and benign breast tumors.

Alzamend Neuro, Inc. today announced that it received notice from the Nasdaq Hearings Panel (the “ Hearings Panel ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”), which granted Alzamend’s request for continued listing on The Nasdaq Capital Market, subject to Alzamend’s satisfaction of the minimum $1.00 bid price requirement by November 15, 2023.

Chime Biologics and Panolos Bioscience have entered into a global strategic collaboration agreement on a novel multi-specific protein drug.

Abbott (NYSE: ABT) today announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.

Optinose today announced that members of its management team will present a company overview and business update at the 2023 Cantor Global Healthcare Conference on September 27, 2023 at 4:45 p.m. ET.

Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that Humana is the fifth national payor in the US to cover focused ultrasound treatment for medication-refractory essential tremor.

University of Texas Medical Branch, Jamaica Hospital Medical Center and University of Chicago unveiled new impact data during the Pulmonary Embolism Symposium illustrating the importance of artificial intelligence in PE care.

Ligand’s Partner Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze ® (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.